Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland
![Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780444640819000061-f06-01-9780444640819.jpg)
Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect
![Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals](http://images.chemnet.com/service/drug_dict/098/11098_1.jpg)
Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals
![LONQUEX Trademark of TEVA Pharmaceutical Industries Ltd. Serial Number: 85427862 :: Trademarkia Trademarks LONQUEX Trademark of TEVA Pharmaceutical Industries Ltd. Serial Number: 85427862 :: Trademarkia Trademarks](https://mark.trademarkia.com/logo-images/tevapharmaceutical-industries-ltd/lonquex-85427862.jpg)